EFFECTS OF THE CATHEPSIN K INHIBITOR, ONO-5334, ON BMD AS MEASURED BY 3D QCT IN THE HIP AND THE SPINE AFTER 2 YEARS OF TREATMENT

被引:0
|
作者
Engelke, Klaus [1 ]
Nagase, Shinishi [2 ]
Fuerst, Thomas [5 ]
Eastell, Richard [3 ]
Genant, Harry K. [4 ]
Samll, Maria [2 ]
Kuwajama, T. [2 ]
Deacon, Steve [2 ]
机构
[1] Synarc, Hamburg, Germany
[2] Ono Pharma UK, London, England
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Synarc, Newark, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S62 / S63
页数:2
相关论文
共 25 条
  • [11] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    Eastell, R.
    Dijk, D. -J.
    Small, M.
    Greenwood, A.
    Sharpe, J.
    Yamada, H.
    Yuba, M.
    Tanimoto, M.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 309 - 318
  • [12] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    R. Eastell
    D.-J. Dijk
    M. Small
    A. Greenwood
    J. Sharpe
    H. Yamada
    M. Yuba
    M. Tanimoto
    S. Deacon
    Osteoporosis International, 2016, 27 : 309 - 318
  • [13] Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO-5334 after ascending single doses in post menopausal women
    Nagase, Shinichi
    Hashimoto, Yoshitaka
    Small, Maria
    Ohyama, Michiyo
    Kuwayama, Tomohiro
    Deacon, Steve
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (06) : 959 - 970
  • [14] Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns
    Tanaka, Makoto
    Hashimoto, Yoshitaka
    Sekiya, Noboru
    Honda, Naoki
    Deacon, Steve
    Yamamoto, Masanobu
    JOURNAL OF BONE AND MINERAL METABOLISM, 2014, 32 (04) : 447 - 454
  • [15] Effects of novel cathepsin K inhibitor ONO-5334 on bone resorption markers: a study of four sustained release formulations with different pharmacokinetic patterns
    Makoto Tanaka
    Yoshitaka Hashimoto
    Noboru Sekiya
    Naoki Honda
    Steve Deacon
    Masanobu Yamamoto
    Journal of Bone and Mineral Metabolism, 2014, 32 : 447 - 454
  • [16] Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO-5334, in an Ascending Multiple-Dose, Phase 1 Study
    Nagase, Shinichi
    Ohyama, Michiyo
    Hashimoto, Yoshitaka
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03): : 306 - 318
  • [17] Modeling and Simulation of Bone Mineral Density Response From a Phase 2 Study of ONO-5334, a New Cathepsin K Inhibitor, to Support Dose Selection in Osteoporosis
    Hasegawa, Chihiro
    Kastrissios, Helen
    Monteleone, Jonathan
    Ohno, Tomoya
    Umemura, Takeo
    Ohyama, Michiyo
    Nagase, Shinichi
    Small, Maria
    Deacon, Steve
    Ogawa, Mikio
    Ieiri, Ichiro
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 937 - 948
  • [18] Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from ocean study
    Eastell, R.
    Nagase, S.
    Boonen, S.
    Spector, T.
    Small, M.
    Kuwayama, T.
    Sawyer, J.
    Deacon, S.
    BONE, 2011, 48 : S92 - S93
  • [19] Regional Differences of Femoral BMD Changes after One Year Once-Monthly Ibandronate as Measured by 3D QCT.
    Engelke, K.
    Fuerst, T.
    Enslin, M.
    Davis, R. Y.
    Fitzpatrick, L. A.
    Ethgen, D.
    Genant, H. K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S306 - S306
  • [20] Changes in volumetric BMD and cortical thickness measured by 3D-DXA in the lumbar spine after 24 months of Denosumab treatment.
    Lopez Picazo, Mirella
    Humbert, Ludovic
    Gonzalez Ballester, Miguel Angel
    Del Rio, Luis
    Winzenrieth, Renaud
    Di Gregorio, Silvana
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S293 - S294